Chemomab Therapeutics Stock (NASDAQ: CMMB) stock price, news, charts, stock research, profile.
Open | $0.639 |
Close | - |
Volume / Avg. | 22.402K / 218.368K |
Day Range | 0.620 - 0.646 |
52 Wk Range | 0.420 - 1.890 |
Market Cap | $8.835M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.58% |
Days to Cover | 2.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Chemomab Therapeutics (NASDAQ: CMMB) through any online brokerage.
Other companies in Chemomab Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Monopar Therapeutics (NASDAQ:MNPR), Can Fite Biofarma (AMEX:CANF) and BioRestorative Therapies (NASDAQ:BRTX).
The latest price target for Chemomab Therapeutics (NASDAQ: CMMB) was reported by Oppenheimer on Friday, March 8, 2024. The analyst firm set a price target for 0.00 expecting CMMB to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $0.6826 last updated Today at April 26, 2024 at 8:14 AM EDT.
There are no upcoming dividends for Chemomab Therapeutics.
Chemomab Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Chemomab Therapeutics.
Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.